安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Trastuzumab - Wikipedia
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer [29] [26] [30] [31] It is specifically used for cancer that is HER2 receptor positive [29] It may be used by itself or together with other chemotherapy medication [29]
- Trastuzumab Uses, Side Effects Warnings - Drugs. com
Trastuzumab: side effects, dosage, interactions, FAQs, reviews Used for: breast cancer, breast cancer, adjuvant, breast cancer, metastatic, esophageal carcinoma, and more
- Herceptin (Trastuzumab): Side Effects, How it Works, and More
Herceptin (trastuzumab) can be an effective treatment both before and after surgery for people with HER2-positive breast cancer Learn more
- Trastuzumab - NCI - National Cancer Institute
Trastuzumab works by binding to HER2, a protein found in high levels on some cancer cells and causes them to grow Trastuzumab blocks the activity of HER2 and triggers a type of immune reaction that kills cells that have a lot of HER2 It is a type of targeted therapy drug called a monoclonal antibody
- Trastuzumab - StatPearls - NCBI Bookshelf
Trastuzumab is an FDA-approved antineoplastic biologic that targets HER2-positive breast and gastric cancer
- Trastuzumab (intravenous route) - Mayo Clinic
Trastuzumab injection is used to treat HER2-overexpressing new or metastatic (cancer that has spread) breast cancer It can be used alone or with other cancer medicines (eg, carboplatin, cyclophosphamide, docetaxel, doxorubicin, paclitaxel)
- Trastuzumab (Herceptin) | Cancer information - Cancer Research UK
Trastuzumab works by locking onto HER2 on the cancer cells The aim is to stop the cells from growing and kills them Trastuzumab only works if your cancer is HER2 positive You have tests on your cancer cells to check for this You might have the original drug called Herceptin, or a biosimilar
- Trastuzumab (Herceptin®) - OncoLink
Trastuzumab (Herceptin®) is a monoclonal antibody used in the treatment of HER2 positive breast cancer, metastatic gastric and gastroesophageal junction adenocarcinoma
|
|
|